Matches in Wikidata for { <http://www.wikidata.org/entity/Q69095832> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q69095832 description "article scientifique publié en 1989" @default.
- Q69095832 description "artigo científico (publicado na 1989)" @default.
- Q69095832 description "artikull shkencor i botuar më 01 janar 1989" @default.
- Q69095832 description "artículu científicu espublizáu en 1989" @default.
- Q69095832 description "im Januar 1989 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69095832 description "scientific article published on 01 January 1989" @default.
- Q69095832 description "wetenschappelijk artikel" @default.
- Q69095832 description "наукова стаття, опублікована в січні 1989" @default.
- Q69095832 name "Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study" @default.
- Q69095832 name "Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study" @default.
- Q69095832 name "Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study" @default.
- Q69095832 type Item @default.
- Q69095832 label "Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study" @default.
- Q69095832 label "Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study" @default.
- Q69095832 label "Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study" @default.
- Q69095832 prefLabel "Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study" @default.
- Q69095832 prefLabel "Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study" @default.
- Q69095832 prefLabel "Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study" @default.
- Q69095832 P1433 Q69095832-587274E3-F8E0-4D62-A087-B94977C2A964 @default.
- Q69095832 P1476 Q69095832-2022B3D8-E8E6-4752-8100-B0652BED117A @default.
- Q69095832 P2093 Q69095832-13B128ED-9300-4DCD-B28D-1CC75B795D96 @default.
- Q69095832 P2093 Q69095832-76BFBA58-5531-4EB6-88CD-B866B2141D6B @default.
- Q69095832 P2093 Q69095832-B7D9177E-B689-45DF-BF8C-36FD810B5117 @default.
- Q69095832 P2093 Q69095832-B854CA72-B54B-4826-B169-FC29D52D2359 @default.
- Q69095832 P304 Q69095832-EA41F6B8-42C6-4B79-A925-F87C6D269270 @default.
- Q69095832 P31 Q69095832-481BD83F-B5AD-43A6-8A3A-807B1BE79622 @default.
- Q69095832 P356 Q69095832-BE4D3460-8909-47F8-B775-0495E2120208 @default.
- Q69095832 P478 Q69095832-970A4847-9F55-49E6-8C03-1F0D1C6D7810 @default.
- Q69095832 P577 Q69095832-4D262EBF-A329-4B89-9204-72827C9E4563 @default.
- Q69095832 P698 Q69095832-FDD05DF3-ABDB-4179-B7F1-5A6323CA2ABA @default.
- Q69095832 P921 Q69095832-4C1AA49D-63E9-41D4-B2A3-4BE174BAC39C @default.
- Q69095832 P921 Q69095832-8459DF1D-AE6D-4EDD-B0C9-0F6C4937720B @default.
- Q69095832 P356 00005344-198900134-00013 @default.
- Q69095832 P698 2475686 @default.
- Q69095832 P1433 Q2125808 @default.
- Q69095832 P1476 "Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study" @default.
- Q69095832 P2093 "A Schumacher" @default.
- Q69095832 P2093 "G Pfennigsdorf" @default.
- Q69095832 P2093 "J Sosna" @default.
- Q69095832 P2093 "S Speders" @default.
- Q69095832 P304 "S47-9" @default.
- Q69095832 P31 Q13442814 @default.
- Q69095832 P356 "10.1097/00005344-198900134-00013" @default.
- Q69095832 P478 "13 Suppl 4" @default.
- Q69095832 P577 "1989-01-01T00:00:00Z" @default.
- Q69095832 P698 "2475686" @default.
- Q69095832 P921 Q410291 @default.
- Q69095832 P921 Q988405 @default.